HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.
about
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsEarly erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsHypoxic regulation of erythropoiesis and iron metabolismRecent trends in erythropoietin-mediated neuroprotectionPten dose dictates cancer progression in the prostateErythropoietin in ophthalmology: A literature reviewHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionIron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiencyHypoxia-inducible factors in the kidneyHIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemiaGene expression microarray analysis of early oxygen-induced retinopathy in the ratHypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivoThe mouse retina as an angiogenesis model.Retinopathy of prematurity: current concepts in molecular pathogenesis.Vascular responses to hypoxia and ischemia.MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivoThe alternative complement pathway regulates pathological angiogenesis in the retinaStudies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Cedilanid inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.Mitigation of oxygen-induced retinopathy in α2β1 integrin-deficient mice.HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolismInvolvement of erythropoietin in retinal ischemic preconditioning.MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.Combinatorial Gata2 and Sca1 expression defines hematopoietic stem cells in the bone marrow niche.Gene expression changes in a rat model of oxygen-induced retinopathy.Survival and proliferative roles of erythropoietin beyond the erythroid lineage.Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner.Prolyl hydroxylase domain protein 2 (PHD2) mediates oxygen-induced retinopathy in neonatal miceTargeting Neovascularization in Ischemic Retinopathy: Recent AdvancesSubtle variations in Pten dose determine cancer susceptibilityStimulating retinal blood vessel protection with hypoxia-inducible factor stabilization: identification of novel small-molecule hydrazones to inhibit hypoxia-inducible factor prolyl hydroxylase (an American Ophthalmological Society thesis).Hypoxia inducible factor-2α regulates the development of retinal astrocytic network by maintaining adequate supply of astrocyte progenitorsSpecific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages.Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin.Sirtuin 1: A Target for Kidney Diseases.Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma.Endothelial cell proliferation in the choriocapillaris during human retinal differentiation.Anaemia in kidney disease: harnessing hypoxia responses for therapy
P2860
Q24195000-51CC6B6B-0092-47D6-BAB0-D47409C43214Q24200642-C9408B6D-230C-42D0-A2B3-B1303FE3DE5EQ24245418-4C559529-A743-4C2F-AE1A-AE36329B1DB5Q24609166-B367B346-6DB9-4CFA-A198-4ED10B505D2CQ24649547-4E3EE4F9-631E-449A-B5F2-65770EB2E4D2Q24791909-B157B76E-2E4A-47F9-9EDA-A660E1EB0E34Q26744850-55B37880-6376-4DFC-8B11-BA1F58566C36Q27025886-7F47D428-810F-4CCF-AA87-A7DD1B3CBB87Q28297161-F071B027-3C59-4084-867A-463A5ADBB168Q28303287-66BA747F-4826-4375-A1FF-AF6D8362A3E8Q28474375-05A71320-6CDF-402C-908F-347DF4FF8DBFQ28577253-C8C68370-EDEB-4968-821B-483C13F36977Q28594830-2D9D7795-B0F1-4ED0-B4B8-FEF16EE2EF14Q30495106-AB01CBC5-61D5-497D-B9D9-0539EA11DCF3Q33606227-1476ABAC-884C-42BC-916E-221BEB130CCDQ33739281-10A3AC5F-A991-46E2-94C5-D8E70FE9AC1EQ33760162-9357BCF1-F7A5-40CF-9655-9625F716E642Q33775122-CC7499A2-8988-4741-A9BC-DED47F832B0EQ33787955-9B15E8AB-58C3-4A89-84E4-0346F2FFACE2Q33828646-38D7DB14-79DF-4057-BE12-DA34BD773241Q33868764-62917B3E-F1AB-4723-A787-C24C2C895CC8Q33915935-C1C23603-4395-496B-BC35-9931D34760A9Q33926530-D626FF82-3752-4321-A484-786F38263AE8Q33937354-DE17BC64-6F38-4821-98E5-BF4D540EC0F4Q34182469-FF14CE0A-C748-4CD4-8FC9-D7BB5E97C490Q34479030-A81932C7-8418-4387-9261-E1AD1352C769Q34575052-D27271F6-C358-48AF-B6FF-2A7CB5BD88A2Q34725972-79EBF4D1-13DC-4592-A6A0-4C86CBB0DB80Q34799862-D394B7B5-79CD-4994-B217-FC639CE6677DQ34805681-D087E9CE-3E3E-47A7-9026-1C6ACC4EEF8EQ34972210-718C1ACB-1F2F-4834-B56D-5ED2A74E8BE3Q35055350-CAD32FD2-35A2-48B7-8E6E-078E55097B4EQ35079777-18D0E5E8-7D5A-4DDD-8847-8DDF475E9755Q35086465-7707C8E5-A9DA-481B-A625-B877DEEE28DDQ35192634-38603638-8D88-4E60-A7E0-0E9EF256643BQ35587285-AB670201-77B9-4B50-B293-8D475E444523Q35707150-822203C4-1916-4A56-9848-8BC39B4C57C4Q35759042-B0A81360-2805-426C-ADD8-246A4FBA6E0EQ35762038-C7449B5F-200B-4667-9D65-0FED7E73D41BQ35836904-07B060C7-735D-4584-9145-F0AB78FAF4B3
P2860
HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@ast
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@en
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@nl
type
label
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@ast
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@en
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@nl
prefLabel
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@ast
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@en
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@nl
P2093
P2860
P356
P1433
P1476
HLF/HIF-2alpha is a key factor ...... sociation with erythropoietin.
@en
P2093
Kazuhiro Sogawa
Koji Tomita
Makoto Tamai
Masanobu Morita
Masayuki Yamamoto
Norio Suzuki
Osamu Nakajima
Osamu Ohneda
Satoru Takahashi
Shigeki Shibahara
P2860
P304
P356
10.1093/EMBOJ/CDG117
P407
P577
2003-03-01T00:00:00Z